India is facing a high burden of infertility, with approximately 22-33 million couples suffering from lifetime infertility. Female factor for infertility accounts for 40-50% among these couples, while the male factor , which is on the rise in India, accounts for 30-40%. With the increasing number of infertility cases, India has become one of the top destinations for In-vitro fertilization (IVF) treatments.
It is estimated that by the year 2022, the country’s market for IVF is expected to grow to Rs 500 crore. This may be due to an increasing number of childless couples adopting artificial medical treatment to achieve blissful parenthood. However, several questions arise before opting for this technique: ‘How much does this treatment cost?’; ‘What is the success rate of this treatment?’; ‘Is the cost v/s benefit ratio justified by the success rate?’ When we compare the cost for one…
